FY2025 EPS Estimates for Humana Boosted by Cantor Fitzgerald

Humana Inc. (NYSE:HUM - Free Report) - Investment analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of Humana in a research note issued on Wednesday, February 12th. Cantor Fitzgerald analyst S. James now forecasts that the insurance provider will post earnings per share of $16.27 for the year, up from their previous forecast of $16.17. Cantor Fitzgerald has a "Neutral" rating and a $290.00 price objective on the stock. The consensus estimate for Humana's current full-year earnings is $16.11 per share.

Other research analysts have also issued research reports about the company. Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a report on Monday, January 6th. Royal Bank of Canada restated an "outperform" rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Finally, Bank of America raised shares of Humana from an "underperform" rating to a "neutral" rating and increased their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $293.05.

Humana Price Performance

Shares of NYSE:HUM traded up $0.73 on Thursday, reaching $253.61. The company's stock had a trading volume of 2,386,047 shares, compared to its average volume of 1,515,752. The company has a 50-day simple moving average of $271.27 and a 200 day simple moving average of $292.96. Humana has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $30.54 billion, a P/E ratio of 22.46, a PEG ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of HUM. Pinnacle Wealth Management Advisory Group LLC raised its holdings in shares of Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock valued at $272,000 after acquiring an additional 37 shares during the last quarter. Atlas Brown Inc. raised its stake in Humana by 0.6% in the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after purchasing an additional 38 shares during the last quarter. Moors & Cabot Inc. lifted its holdings in Humana by 2.5% in the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock valued at $519,000 after purchasing an additional 40 shares in the last quarter. Mather Group LLC. boosted its stake in Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after purchasing an additional 41 shares during the last quarter. Finally, Capital Advisors Ltd. LLC grew its holdings in shares of Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after buying an additional 43 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.32% of the company's stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.